Accession Therapeutics
Accession Therapeutics raised US$34.7M in Series A funding.
Email and contact information
Company website: www.accessiontherapeutics.com
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Oxford, Oxfordshire (United Kingdom)
Industry: Biopharma, Biotechnology
Business model:
Funding
- Total funding amount: $34,660,221 (in USD)
- Estimated valuation: $173,301,105.00
- Latest deal type: Series A
- First fundind year: 2022
Growth
Founders: Bent Jakobsen, Francis Yuan, Nick Cross
Top investors: iGlobe Partners, Primavera Capital Group, Birk Venture
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK